Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Osteoporosis in Men
NCT00439647Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2006
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 23
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Zoledronic Acid with Placebo (2 arms). Primary endpoint: Percentage of Participants With at Least One New Morphometric Vertebral Fracture at 24 months. Started Dec 2006; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00439647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439647.